Cargando…
POS-940 ANTIBODY RESPONSE TO PFIZER BNT162b2 VACCINE IN HEMODIALYSIS PATIENTS: THE PREVIOUS SARS-CoV-2 INFECTION INFLUENCE
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854956/ http://dx.doi.org/10.1016/j.ekir.2022.01.980 |
_version_ | 1784653548285329408 |
---|---|
author | FREITAS, M. Francisco, J. Beirão, B. Pereira, P. Sousa, C. Oliveira, L. Morgado, T. |
author_facet | FREITAS, M. Francisco, J. Beirão, B. Pereira, P. Sousa, C. Oliveira, L. Morgado, T. |
author_sort | FREITAS, M. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8854956 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88549562022-02-18 POS-940 ANTIBODY RESPONSE TO PFIZER BNT162b2 VACCINE IN HEMODIALYSIS PATIENTS: THE PREVIOUS SARS-CoV-2 INFECTION INFLUENCE FREITAS, M. Francisco, J. Beirão, B. Pereira, P. Sousa, C. Oliveira, L. Morgado, T. Kidney Int Rep Article Published by Elsevier Inc. 2022-02 2022-02-18 /pmc/articles/PMC8854956/ http://dx.doi.org/10.1016/j.ekir.2022.01.980 Text en Copyright © 2022 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article FREITAS, M. Francisco, J. Beirão, B. Pereira, P. Sousa, C. Oliveira, L. Morgado, T. POS-940 ANTIBODY RESPONSE TO PFIZER BNT162b2 VACCINE IN HEMODIALYSIS PATIENTS: THE PREVIOUS SARS-CoV-2 INFECTION INFLUENCE |
title | POS-940 ANTIBODY RESPONSE TO PFIZER BNT162b2 VACCINE IN HEMODIALYSIS PATIENTS: THE PREVIOUS SARS-CoV-2 INFECTION INFLUENCE |
title_full | POS-940 ANTIBODY RESPONSE TO PFIZER BNT162b2 VACCINE IN HEMODIALYSIS PATIENTS: THE PREVIOUS SARS-CoV-2 INFECTION INFLUENCE |
title_fullStr | POS-940 ANTIBODY RESPONSE TO PFIZER BNT162b2 VACCINE IN HEMODIALYSIS PATIENTS: THE PREVIOUS SARS-CoV-2 INFECTION INFLUENCE |
title_full_unstemmed | POS-940 ANTIBODY RESPONSE TO PFIZER BNT162b2 VACCINE IN HEMODIALYSIS PATIENTS: THE PREVIOUS SARS-CoV-2 INFECTION INFLUENCE |
title_short | POS-940 ANTIBODY RESPONSE TO PFIZER BNT162b2 VACCINE IN HEMODIALYSIS PATIENTS: THE PREVIOUS SARS-CoV-2 INFECTION INFLUENCE |
title_sort | pos-940 antibody response to pfizer bnt162b2 vaccine in hemodialysis patients: the previous sars-cov-2 infection influence |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854956/ http://dx.doi.org/10.1016/j.ekir.2022.01.980 |
work_keys_str_mv | AT freitasm pos940antibodyresponsetopfizerbnt162b2vaccineinhemodialysispatientstheprevioussarscov2infectioninfluence AT franciscoj pos940antibodyresponsetopfizerbnt162b2vaccineinhemodialysispatientstheprevioussarscov2infectioninfluence AT beiraob pos940antibodyresponsetopfizerbnt162b2vaccineinhemodialysispatientstheprevioussarscov2infectioninfluence AT pereirap pos940antibodyresponsetopfizerbnt162b2vaccineinhemodialysispatientstheprevioussarscov2infectioninfluence AT sousac pos940antibodyresponsetopfizerbnt162b2vaccineinhemodialysispatientstheprevioussarscov2infectioninfluence AT oliveiral pos940antibodyresponsetopfizerbnt162b2vaccineinhemodialysispatientstheprevioussarscov2infectioninfluence AT morgadot pos940antibodyresponsetopfizerbnt162b2vaccineinhemodialysispatientstheprevioussarscov2infectioninfluence |